NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · Real-Time Price · USD
3.290
+0.110 (3.46%)
Nov 20, 2024, 4:00 PM EST - Market closed
NLS Pharmaceutics AG Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | -6.6 | -12.17 | -16.5 | -11.95 | -2.86 | -5.45 | Upgrade
|
| Depreciation & Amortization | 0.01 | 0.01 | 0.01 | 0.01 | - | - | Upgrade
|
| Other Amortization | - | - | 0.07 | 0.04 | 0.07 | 0.76 | Upgrade
|
| Stock-Based Compensation | 0.16 | 0.16 | 0.02 | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | 0.08 | - | - | Upgrade
|
| Other Operating Activities | 0.12 | 0.06 | 0.89 | 0.05 | 0.02 | 0.39 | Upgrade
|
| Change in Accounts Receivable | - | - | - | -0.02 | -0.01 | 0 | Upgrade
|
| Change in Accounts Payable | 1.47 | 2.26 | 0.64 | -2.27 | 1.5 | 1.38 | Upgrade
|
| Change in Unearned Revenue | - | - | - | - | - | 2.5 | Upgrade
|
| Change in Other Net Operating Assets | 0.92 | -0.01 | 0.99 | -0.88 | 0.56 | 0.24 | Upgrade
|
| Operating Cash Flow | -3.92 | -9.68 | -13.88 | -14.94 | -0.73 | -0.19 | Upgrade
|
| Capital Expenditures | - | - | - | -0.04 | - | - | Upgrade
|
| Investing Cash Flow | - | - | - | -0.04 | - | - | Upgrade
|
| Short-Term Debt Issued | - | 1.63 | - | 0.11 | 0.68 | 0.51 | Upgrade
|
| Long-Term Debt Issued | - | - | 1.53 | - | 0.51 | 0.15 | Upgrade
|
| Total Debt Issued | 1.63 | 1.63 | 1.53 | 0.11 | 1.19 | 0.67 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -0.78 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -0.7 | -1.43 | - | - | Upgrade
|
| Total Debt Repaid | -0.19 | - | -0.7 | -2.21 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 1.44 | 1.63 | 0.83 | -2.1 | 1.19 | 0.67 | Upgrade
|
| Issuance of Common Stock | 1.38 | - | 9.24 | 15.7 | - | - | Upgrade
|
| Other Financing Activities | - | - | 7.33 | 6.74 | -0.69 | -0.26 | Upgrade
|
| Financing Cash Flow | 2.82 | 1.63 | 17.4 | 20.34 | 0.5 | 0.41 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | - | -0 | -0.02 | 0.1 | -0 | Upgrade
|
| Net Cash Flow | -1.1 | -8.05 | 3.52 | 5.34 | -0.13 | 0.21 | Upgrade
|
| Free Cash Flow | -3.92 | -9.68 | -13.88 | -14.98 | -0.73 | -0.19 | Upgrade
|
| Free Cash Flow Per Share | -3.91 | -10.15 | -28.21 | -50.33 | -4.19 | -1.11 | Upgrade
|
| Cash Interest Paid | 0.15 | 0.15 | 0.01 | 0.34 | - | - | Upgrade
|
| Levered Free Cash Flow | -1.85 | -5 | -8.69 | -10.66 | 0.64 | -0.82 | Upgrade
|
| Unlevered Free Cash Flow | -1.7 | -4.9 | -8.69 | -10.66 | 0.71 | -1.06 | Upgrade
|
| Change in Net Working Capital | -2.07 | -2.3 | -0.95 | 3.22 | -2.15 | -1.56 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.